Laura‐Maria Krabbe

1.1k total citations
46 papers, 651 citations indexed

About

Laura‐Maria Krabbe is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Laura‐Maria Krabbe has authored 46 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 24 papers in Surgery and 12 papers in Oncology. Recurrent topics in Laura‐Maria Krabbe's work include Bladder and Urothelial Cancer Treatments (23 papers), Prostate Cancer Treatment and Research (16 papers) and Urinary and Genital Oncology Studies (14 papers). Laura‐Maria Krabbe is often cited by papers focused on Bladder and Urothelial Cancer Treatments (23 papers), Prostate Cancer Treatment and Research (16 papers) and Urinary and Genital Oncology Studies (14 papers). Laura‐Maria Krabbe collaborates with scholars based in Germany, United States and Austria. Laura‐Maria Krabbe's co-authors include Martin Boegemann, Andres Jan Schrader, Edwin Herrmann, Katrin Schlack, Thomas Schnoeller, Michael Stöeckle, Florian Jentzmik, Mark Schrader, Marcus V. Cronauer and Julie Steinestel and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Laura‐Maria Krabbe

39 papers receiving 637 citations

Peers

Countries citing papers authored by Laura‐Maria Krabbe

Since Specialization

Citations

This map shows the geographic impact of Laura‐Maria Krabbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura‐Maria Krabbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura‐Maria Krabbe more than expected).

Fields of papers citing papers by Laura‐Maria Krabbe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura‐Maria Krabbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura‐Maria Krabbe. The network helps show where Laura‐Maria Krabbe may publish in the future.

Co-authorship network of co-authors of Laura‐Maria Krabbe

This figure shows the co-authorship network connecting the top 25 collaborators of Laura‐Maria Krabbe. A scholar is included among the top collaborators of Laura‐Maria Krabbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura‐Maria Krabbe. Laura‐Maria Krabbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risikoadaptierte Prostatakarzinomfrüherkennung 2.0 – Positionspapier der Deutschen Gesellschaft für Urologie 2024 2024 ·PubMed ·Maurice Stephan Michel, Jürgen E. Gschwend, (unknown), S. Krege, Christian Bolenz, Axel S. Merseburger, Laura‐Maria Krabbe, (unknown), (unknown), Axel Haferkamp, Boris Hadaschik	0
2	Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer 2023 ·Biomarker Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Julie Steinestel, (unknown), Stefan Duensing, Laura‐Maria Krabbe, Martin Bögemann, Andres Jan Schrader, Christof Bernemann, Katrin Schlack	8
3	Artificial Intelligence Reveals Distinct Prognostic Subgroups of Muscle-Invasive Bladder Cancer on Histology Images 2023 ·Cancers ·Okyaz Eminağa, Sami‐Ramzi Leyh‐Bannurah, Shahrokh F. Shariat, Laura‐Maria Krabbe, Hubert Lau, Lei Xing, Mahmoud Abbas	2
4	The treatment of metastatic, hormone-sensitive prostatic carcinoma 2022 ·Deutsches Ärzteblatt international ·Axel S. Merseburger, Laura‐Maria Krabbe, Bernd J. Krause, Dirk Böhmer, Sven Perner, Gunhild von Amsberg	9
5	Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients 2022 ·Scientific Reports ·Katrin Schlack, (unknown), (unknown), (unknown), (unknown), Julie Steinestel, (unknown), Kambiz Rahbar, Laura‐Maria Krabbe, Martin Bögemann, Andres Jan Schrader, Christof Bernemann	9
6	ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysis 2021 ·Translational Andrology and Urology ·Katrin Schlack, Laura‐Maria Krabbe, Kambiz Rahbar, (unknown), Axel Semjonow, Andres Jan Schrader, Martin Boegemann	8
7	Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational Survey 2021 ·Urologia Internationalis ·Julian P. Struck, Martin Hennig, Marie C. Hupe, (unknown), Pia Paffenholz, Tim Nestler, (unknown), Thomas Stefan Worst, Markus Grabbert, (unknown), (unknown), Sebastian Hofbauer, Charis Kalogirou, (unknown), Maximilian Peter Brandt, Laura‐Maria Krabbe, Henning Reis, (unknown), Mario W. Kramer, Johannes Salem	0
8	Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review 2020 ·Investigative and Clinical Urology ·Stefanie Schmidt, Frank Kunath, Bernadette Coles, Désirée Louise Draeger, Laura‐Maria Krabbe, Rick Dersch, Samuel Kilian, Katrin Jensen, Philipp Dahm, Joerg J Meerpohl	3
9	Behandlung des metastasierten Nierenzellkarzinoms mittels zielgerichteter Therapie („targeted therapy“) 2020 ·Der Urologe ·Laura‐Maria Krabbe	1
10	A prognostic score for overall survival in patients treated with abiraterone in the pre- and post-chemotherapy setting 2019 ·Oncotarget ·Martin Boegemann, Katrin Schlack, (unknown), Julie Steinestel, Andres Jan Schrader, (unknown), Laura‐Maria Krabbe, Okyaz Eminağa	4
11	Prognostic Implications of Immunohistochemical Biomarkers in Non-muscle-invasive Blad Cancer and Muscle-invasive Bladder Cancer 2016 ·Mini-Reviews in Medicinal Chemistry ·Martin Boegemann, Laura‐Maria Krabbe	9
12	The safety and efficacy of gemcitabine for the treatment of bladder cancer 2016 ·Expert Review of Anticancer Therapy ·Katrin Schlack, Martin Boegemann, Julie Steinestel, Andres Jan Schrader, Laura‐Maria Krabbe	27
13	Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate 2016 ·PLoS ONE ·Martin Boegemann, Katrin Schlack, (unknown), Joachim Gerß, Julie Steinestel, Axel Semjonow, Andres Jan Schrader, Laura‐Maria Krabbe	18
14	Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease? 2016 ·Translational Andrology and Urology ·(unknown), Katrin Schlack, Martin Boegemann, Julie Steinestel, Andres Jan Schrader, Laura‐Maria Krabbe	39
15	Present, Emerging and Possible Future Biomarkers in Castration Resistant Prostate Cancer (CRPC) 2015 ·Current Cancer Drug Targets ·Martin Boegemann, (unknown), Laura‐Maria Krabbe, Edwin Herrmann	14
16	Dynamic changes of alkaline phosphatase as surrogate for best clinical benefit and overall survival during very early abiraterone therapy compared to PSA-changes in bone metastatic castration resistant prostate cancer. 2015 ·Journal of Clinical Oncology ·Martin Boegemann, (unknown), Okyaz Eminağa, Edwin Herrmann, (unknown), (unknown), Axel Semjonow, Andres Jan Schrader, Laura‐Maria Krabbe	1
17	MP7-01 PREOPERATIVE NOMOGRAM TO PREDICT PERIOPERATIVE COMPLICATIONS AFTER RADICAL NEPHROURETERECTOMY 2015 ·The Journal of Urology ·(unknown), Tobias Klatte, Shahrokh F. Shariat, Laura‐Maria Krabbe, Vitaly Margulis, (unknown), Costas D. Lallas, Edouard J. Trabulsi, G. Bozzini, Pierre Colin, Sarah Drouin, Morgan Rouprêt, B. Peyronnet, Karim Bensalah, (unknown), David Canes, Jay D. Raman	1
18	MP69-14 THE RISK OF PROSTATE CANCER ON SUBSEQUENT BIOPSIES IN MEN WITH HIGH-GRADE PIN AND/OR ASAP IN A PROSPECTIVE STUDY WITH CENTRAL PATHOLOGY (THE REDUCE TRIAL) 2014 ·The Journal of Urology ·Laura‐Maria Krabbe, Claus G. Roehrborn	2
19	Bladder cancer risk: Use of PLCO and NLST to identify a suitable screening cohort. 2014 ·Journal of Clinical Oncology ·Laura‐Maria Krabbe, Robert S. Svatek, Shahrokh F. Shariat, Edward M. Messing, Yair Lotan	4
20	Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: Results of a current series and a review of the literature 2013 ·Urologic Oncology Seminars and Original Investigations ·Laura‐Maria Krabbe, Mary E. Westerman, Aditya Bagrodia, Bishoy A. Gayed, (unknown), Payal Kapur, Shahrokh F. Shariat, Ganesh V. Raj, Arthur I. Sagalowsky, Jeffrey A. Cadeddu, Yair Lotan, Vitaly Margulis	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact